Printer Friendly

ICOS ANNOUNCES RESEARCH AGREEMENT WITH UNIVERSITY OF UTAH

 ICOS ANNOUNCES RESEARCH AGREEMENT WITH UNIVERSITY OF UTAH
 SEATTLE, June 18 /PRNewswire/ -- ICOS Corp. (NASDAQ: ICOS) announced today a research collaboration with the University of Utah. The new agreement covers certain novel cell surface receptors and agonists and antagonists of specific proinflammatory molecules. Under the terms of the agreement, ICOS will have exclusive rights to the technology. In return, the University of Utah may receive future royalties on certain products, and the principal investigators will receive laboratory support.
 "This agreement will enhance work initiated here at ICOS, and will involve collaboration between our scientists and Drs. Stephen M. Prescott, Thomas M. McIntyre and Guy A. Zimmerman, of the University of Utah, who have established international reputations in this field," said Dr. Christopher Henney, executive vice president of Research and Development. He added, "The subject of the agreement fits well into our strategy to develop products based on a broad understanding of all aspects of the inflammatory process."
 ICOS Corp. is a Seattle-based biopharmaceutical company founded to develop medications for the treatment of chronic inflammatory diseases. Primary targets of the company's drug and research development program include asthma, multiple sclerosis and rheumatoid arthritis.
 -0- 6/18/92
 /CONTACT: Janice M. LeCocq of ICOS, 206-485-1900/
 (ICOS) CO: ICOS Corp.; University of Utah ST: Washington, Utah IN: MTC SU:


LM-SC -- SE001 -- 1375 06/18/92 09:02 EDT
COPYRIGHT 1992 PR Newswire Association LLC
No portion of this article can be reproduced without the express written permission from the copyright holder.
Copyright 1992 Gale, Cengage Learning. All rights reserved.

Article Details
Printer friendly Cite/link Email Feedback
Publication:PR Newswire
Date:Jun 18, 1992
Words:225
Previous Article:WICAT'S NEW ADULT EDUCATION CURRICULUM ADDED TO THE NATIONAL DEMONSTRATION LABORATORY AT THE LIBRARY OF CONGRESS
Next Article:HALLADOR PETROLEUM RECEIVES $1 MILLION DEMAND FROM CONOCO
Topics:


Related Articles
ICOS ANNOUNCES RESEARCH AGREEMENT WITH DOHENY EYE INSTITUTE
ICOS REPORTS SECOND-QUARTER RESULTS
ICOS REPORTS 1993 SECOND QUARTER RESULTS
ICOS REPORTS 1994 FIRST QUARTER RESULTS
ICOS CORPORATION INITIATES ENROLLMENT OF PHASE 1 STUDY
ICOS AND ABBOTT ESTABLISH COLLABORATION
ICOS ANNOUNCES PHASE 1 STUDY
ICOS REPORTS 1996 FIRST QUARTER RESULTS
ICOS REPORTS 1996 SECOND QUARTER RESULTS
Alanex and ICOS Sign Collaboration to Discover Small Molecule Drugs

Terms of use | Copyright © 2016 Farlex, Inc. | Feedback | For webmasters